Vincent Forlenza to Become BD's Next President, CEO | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today announced that its board has elected Vincent Forlenza to take over as the company's CEO starting Oct. 1, replacing Edward Ludwig.

Forlenza who joined BD in 1980 is currently president and chief operating officer at BD. He will remain President upon becoming the firm's CEO, BD said. Starting Oct. 1, he also will become a member of the board.

Ludwig will serve as executive chairman of the board starting Oct. 1 continuing through June 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.